Vertex Pharmaceuticals (VRTX) ROA - Return on Assets

Current and historical Return on Equity (ROE) values for Vertex Pharmaceuticals (VRTX) over the last 10 years.

Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $44.599B $2.489B
Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.